BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38363278)

  • 1. A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias.
    Chouairi F; Rajkumar K; Benak A; Qadri Y; Piccini JP; Mathew J; Ray ND; Toman J; Kautzner J; Ganesh A; Sramko M; Fudim M
    JACC Clin Electrophysiol; 2024 Apr; 10(4):750-758. PubMed ID: 38363278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias.
    Fudim M; Qadri YJ; Waldron NH; Boortz-Marx RL; Ganesh A; Patel CB; Podgoreanu MV; Sun AY; Milano CA; Tong BC; Harpole DH; Mathew JP; Piccini JP
    JACC Clin Electrophysiol; 2020 May; 6(5):562-571. PubMed ID: 32439042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Stellate Ganglion Blockade in Managing Electrical Storm: A Systematic Review.
    Meng L; Tseng CH; Shivkumar K; Ajijola O
    JACC Clin Electrophysiol; 2017 Sep; 3(9):942-949. PubMed ID: 29270467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stellate ganglion blockade and bilateral cardiac sympathetic denervation in patients with life-threatening ventricular arrhythmias.
    Cardona-Guarache R; Padala SK; Velazco-Davila L; Cassano A; Abbate A; Ellenbogen KA; Koneru JN
    J Cardiovasc Electrophysiol; 2017 Aug; 28(8):903-908. PubMed ID: 28471068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias.
    Ganesh A; Qadri YJ; Boortz-Marx RL; Al-Khatib SM; Harpole DH; Katz JN; Koontz JI; Mathew JP; Ray ND; Sun AY; Tong BC; Ulloa L; Piccini JP; Fudim M
    Curr Hypertens Rep; 2020 Oct; 22(12):100. PubMed ID: 33097982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stellate Ganglion Blockade With Continuous Infusion Versus Single Injection for Treatment of Ventricular Arrhythmia Storm.
    Sanghai S; Abbott NJ; Dewland TA; Henrikson CA; Elman MR; Wollenberg M; Ivie R; Gonzalez-Sotomayor J; Nazer B
    JACC Clin Electrophysiol; 2021 Apr; 7(4):452-460. PubMed ID: 33358672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective Use of Percutaneous Stellate Ganglion Blockade in Patients With Electrical Storm.
    Tian Y; Wittwer ED; Kapa S; McLeod CJ; Xiao P; Noseworthy PA; Mulpuru SK; Deshmukh AJ; Lee HC; Ackerman MJ; Asirvatham SJ; Munger TM; Liu XP; Friedman PA; Cha YM
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007118. PubMed ID: 31514529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysis.
    Fudim M; Boortz-Marx R; Ganesh A; Waldron NH; Qadri YJ; Patel CB; Milano CA; Sun AY; Mathew JP; Piccini JP
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1460-1467. PubMed ID: 28833780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left stellate ganglion block, a rescue treatment for ventricular arrhythmia refractory to radiofrequency catheter ablation: A care-compliant case report.
    Yang SC; Wu CC; Hsieh YJ
    Medicine (Baltimore); 2019 Nov; 98(44):e17790. PubMed ID: 31689853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stellate ganglion blockade for treating refractory electrical storm: a historical cohort study.
    Reinertsen E; Sabayon M; Riso M; Lloyd M; Spektor B
    Can J Anaesth; 2021 Nov; 68(11):1683-1689. PubMed ID: 34312821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous stellate ganglion block suppressing VT and VF in a patient refractory to VT ablation.
    Hayase J; Patel J; Narayan SM; Krummen DE
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):926-8. PubMed ID: 23574305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Ultrasound-Guided Sympathetic Blockade by Proximal Intercostal Block in Electrical Storm Patients.
    Batnyam U; Vlassakov KV; Halawa A; Seligson E; ; Chen L; Redouane B; Janfaza D; Tedrow UB
    JACC Clin Electrophysiol; 2024 Apr; 10(4):734-746. PubMed ID: 38300210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Repeated stellate ganglion blockade for the treatment of ventricular tachycardia storm in patients with nonischemic cardiomyopathy: a new therapeutic option for patients with malignant arrhythmias].
    Cui C; Zhou XK; Zhu Y; Shen YM; Chen LD; Ju WZ; Chen HW; Gu K; Li MF; Pan YB; Chen ML
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):521-525. PubMed ID: 37198124
    [No Abstract]   [Full Text] [Related]  

  • 14. Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series.
    Küçükbingöz Ç; Tepe Ö; Özmen Ç; Özbek HT; Deniz A
    Medicine (Baltimore); 2023 Jun; 102(26):e34135. PubMed ID: 37390263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stellate ganglion block catheters for refractory electrical storm: a retrospective cohort and care pathway.
    Patel RA; Condrey JM; George RM; Wolf BJ; Wilson SH
    Reg Anesth Pain Med; 2023 May; 48(5):224-228. PubMed ID: 36725213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks.
    Fudim M; Boortz-Marx R; Patel CB; Sun AY; Piccini JP
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):446-449. PubMed ID: 28019045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients.
    Goldenberg I; Aktas MK; Zareba W; Tsu-Chau Huang D; Rosero SZ; Younis A; McNitt S; Stockburger M; Steinberg JS; Buttar RS; Merkely B; Kutyifa V
    JACC Clin Electrophysiol; 2024 Jan; 10(1):16-26. PubMed ID: 38032575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.